CA1055934A - Derivatives of rifamycin - Google Patents

Derivatives of rifamycin

Info

Publication number
CA1055934A
CA1055934A CA210,125A CA210125A CA1055934A CA 1055934 A CA1055934 A CA 1055934A CA 210125 A CA210125 A CA 210125A CA 1055934 A CA1055934 A CA 1055934A
Authority
CA
Canada
Prior art keywords
rifamycin
piperazinyl
atoms
group
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA210,125A
Other languages
English (en)
French (fr)
Other versions
CA210125S (en
Inventor
Hans Bickel
Wilhelm Kump
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1396473A external-priority patent/CH594676A5/de
Priority claimed from CH1396673A external-priority patent/CH594677A5/de
Priority claimed from CH1031474A external-priority patent/CH622797A5/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of CA1055934A publication Critical patent/CA1055934A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D269/00—Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA210,125A 1973-09-28 1974-09-26 Derivatives of rifamycin Expired CA1055934A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1396473A CH594676A5 (en) 1973-09-28 1973-09-28 3-(4-Substd.-1-piperazinyl) rifamycin S and SV derivs
CH1396673A CH594677A5 (en) 1973-09-28 1973-09-28 3-(4-Substd.-1-piperazinyl) rifamycin S and SV derivs
CH1031474A CH622797A5 (en) 1974-07-26 1974-07-26 Process for the preparation of antibiotically active rifamycin S and SV derivatives

Publications (1)

Publication Number Publication Date
CA1055934A true CA1055934A (en) 1979-06-05

Family

ID=27176412

Family Applications (1)

Application Number Title Priority Date Filing Date
CA210,125A Expired CA1055934A (en) 1973-09-28 1974-09-26 Derivatives of rifamycin

Country Status (24)

Country Link
JP (1) JPS6012358B2 (bg)
AR (2) AR211845A1 (bg)
AT (1) AT331406B (bg)
BG (2) BG25231A3 (bg)
CA (1) CA1055934A (bg)
CS (1) CS199258B2 (bg)
DD (1) DD114951A5 (bg)
DE (1) DE2444728A1 (bg)
DK (1) DK145949C (bg)
EG (1) EG11775A (bg)
ES (1) ES430524A1 (bg)
FI (1) FI241674A (bg)
FR (1) FR2245359B1 (bg)
GB (1) GB1483621A (bg)
HU (1) HU175580B (bg)
IE (1) IE39919B1 (bg)
IL (1) IL45735A (bg)
NL (1) NL7412729A (bg)
NO (1) NO743174L (bg)
OA (1) OA04783A (bg)
RO (1) RO71721A (bg)
SE (1) SE420494B (bg)
SU (2) SU644388A3 (bg)
YU (2) YU39929B (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1486118A (en) * 1975-03-05 1977-09-21 Lepetit Spa Rifamycin derivatives
US7879834B2 (en) 2004-08-19 2011-02-01 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
EP1973543A2 (en) 2005-12-22 2008-10-01 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
CA2656183A1 (en) 2006-06-29 2008-01-10 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors

Also Published As

Publication number Publication date
FI241674A (bg) 1975-03-29
YU261174A (en) 1982-05-31
YU312980A (en) 1982-10-31
HU175580B (hu) 1980-09-28
DE2444728A1 (de) 1975-04-10
SE7410465L (bg) 1975-04-01
BG25231A3 (bg) 1978-08-10
AR223798A1 (es) 1981-09-30
SE420494B (sv) 1981-10-12
RO71721A (ro) 1982-10-26
JPS6012358B2 (ja) 1985-04-01
IL45735A0 (en) 1974-11-29
SU644388A3 (ru) 1979-01-25
YU39929B (en) 1985-06-30
JPS5063000A (bg) 1975-05-29
OA04783A (fr) 1980-08-31
ATA778874A (de) 1975-11-15
BG25378A3 (bg) 1978-09-15
SU652895A3 (ru) 1979-03-15
NL7412729A (nl) 1975-04-02
DK145949B (da) 1983-04-25
DK145949C (da) 1983-09-26
EG11775A (en) 1977-10-31
IE39919L (en) 1975-03-28
DD114951A5 (bg) 1975-09-05
AR211845A1 (es) 1978-03-31
NO743174L (bg) 1975-04-28
YU40242B (en) 1985-08-31
AU7374774A (en) 1976-04-01
ES430524A1 (es) 1976-10-16
IE39919B1 (en) 1979-01-31
DK422874A (bg) 1975-05-20
GB1483621A (en) 1977-08-24
IL45735A (en) 1978-09-29
CS199258B2 (en) 1980-07-31
FR2245359B1 (bg) 1978-07-21
FR2245359A1 (bg) 1975-04-25
AT331406B (de) 1976-08-25

Similar Documents

Publication Publication Date Title
Cynamon et al. Antimycobacterial activity of a series of pyrazinoic acid esters
GB2053894A (en) Benzodiazepines processes for producing them and compositions containing them
Holshouser et al. Synthesis and antitumor activity of a series of sulfone analogs of 1, 4-naphthoquinone
CZ279772B6 (cs) Substituované benzimidazoly, způsob jejich výroby a jejich farmaceutické použití
JPH02145586A (ja) 新規アルテミシニン誘導体及びその製法
US3836527A (en) Water-soluble sterol sulfates
EP0244398B1 (de) Substituierte 4-benzyl-piperazinyl-verbindungen
CA1055934A (en) Derivatives of rifamycin
Wan et al. Antimalarial quinones for prophylaxis based on a rationale of inhibition of electron transfer in Plasmodium
EP0303571A1 (de) Biphenylyl-Verbindungen
KR900006760B1 (ko) 아실-보효소 a : 콜레스테롤 아실 전이 효소의 억제제로서 올레인산, 리놀산 또는 리놀렌산의 치환 아닐리드 및 그 제조방법
EP0211157B1 (de) Isoxazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Präparate
Szkaradek et al. Synthesis and antimycobacterial assay of some xanthone derivatives
US4006183A (en) Substituted α-methylsulfinyl-o-toluidines
US3174994A (en) Hypocholesterolemic n-oxide compositions
IL28867A (en) 1-adamantyl and 1-adamantylmethyl carbonates of testosterone and derivatives thereof
US3573321A (en) Benzimidazole-2-carbamates substituted on the benzene ring
US3622610A (en) Sulfonate esters of gallic acid derivatives
US3553217A (en) 2-(quinolinimido)glutarimide
US3734944A (en) Glycyrrhetinic acid esters
US3708514A (en) Alpha-(p-chlorophenoxy)isobutyric acid derivatives
US3912767A (en) Novel sulfonate esters of 2-hydroxy-3-(methylthio)-1,4-naphthoquinone
CN114591201B (zh) 具有HDACi药效团的β-榄香烯衍生物及其制备方法和应用
IL37729A (en) 1,4-bis-(3-(substituted methane)sulfonyloxy-propionyl)-piperazine derivatives,their manufacture and pharmaceutical compositions containing them
EP3868768B1 (en) Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, and uses thereof